13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • EXAMINE

    Acronym: 

    EXAMINE

    ACTRN/NCT /ethics: 

    Scientific title: 

    Personalised immunotherapy for pancreatic cancer

    Summary of trial and patient characteristics

    Cancer Type Pancreas
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases Tumour Stream Pancreas
    Age Range 18 years and older Cancer Stage
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Pancreas
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Pancreas
    Cancer Stage
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Lay Summary

    Personalised immunotherapy for pancreatic cancer

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Not Yet Recruiting